3,882
edits
Changes
HAEM5:Volunteer Assignments and Opportunities (view source)
Revision as of 12:48, 18 December 2023
, 12:48, 18 December 2023no edit summary
Line 608:
Line 608:
|Myeloid/lymphoid neoplasm with PDGFRA rearrangement
|Myeloid/lymphoid neoplasm with PDGFRA rearrangement
|Disease
|Disease
−|Jay Alden, DO
+|
|
|
|
|
Line 616:
Line 616:
|
|
|
|
−|
+|Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement
−|
+|Jay Alden, DO
−|
+|Complete
|
|
|
|
Line 624:
Line 624:
|Myeloid/lymphoid neoplasm with PDGFRB rearrangement
|Myeloid/lymphoid neoplasm with PDGFRB rearrangement
|Disease
|Disease
−|Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD
+|
|
|
|
|
Line 632:
Line 632:
|
|
|
|
−|
+|Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement
−|
+|Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD
−|
+|Complete
|
|
|
|
Line 640:
Line 640:
|Myeloid/lymphoid neoplasm with FGFR1 rearrangement
|Myeloid/lymphoid neoplasm with FGFR1 rearrangement
|Disease
|Disease
−|Yanna Ding, MD PhD
+|
|
|
|
|
Line 648:
Line 648:
|
|
|
|
−|
+|Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
−|
+|Yanna Ding, MD PhD
−|
+|Complete
|
|
|
|
Line 656:
Line 656:
|Myeloid/lymphoid neoplasm with JAK2 rearrangement
|Myeloid/lymphoid neoplasm with JAK2 rearrangement
|Disease
|Disease
−|Jessica Snider, M.D. and Daynna J. Wolff, PhD
+|
|
|
|
|
Line 664:
Line 664:
|
|
|
|
−|
+|Myeloid/Lymphoid Neoplasms with PCM1-JAK2 + a non-WHO page Myeloid/Lymphoid Neoplasms with ETV6-JAK2 ([[HAEM4:Myeloid/Lymphoid Neoplasms with ETV6-JAK2|Myeloid/Lymphoid Neoplasms with ETV6-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)]]) + non-WHO page Myeloid/Lymphoid Neoplasms with BCR-JAK2 ([[HAEM4:Myeloid/Lymphoid Neoplasms with BCR-JAK2|Myeloid/Lymphoid Neoplasms with BCR-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)]] ) - both non-WHO pages are authored by trainee Lauren Crowson-Hindman and Daynna Wolff
−|
+|Jessica Snider, M.D. and Daynna J. Wolff, PhD + non-WHO pages by trainee Lauren Crowson-Hindman and Daynna Wolff
−|
+|Complete
|
|
|
|